Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Kalaris Therapeutics has appointed Liisa Bayko, an experienced biotechnology finance leader and analyst, as Chief Financial Officer. This strategic hire strengthens the leadership team during the ongoing Phase 1b/2 clinical trial of TH103, a novel biologic targeting neovascular age-related macular degeneration and other retinal diseases. Bayko's ex…
Outdoor Holding Company (NASDAQ: POWW/POWWP), owner of GunBroker.com, will release its financial results for the first quarter of fiscal year 2027 premarket on August 10, 2026, followed by a management conference call to discuss performance and corporate updates.
DLH Holdings Corp. announced it will release its fiscal third quarter 2026 financial results on July 29, 2026, after market close. The company will host a conference call on July 30, 2026, to discuss the results and operating trends with senior management. The call includes a presentation and a Q&A session, with materials available on the company's…
MiMedx Group, Inc., a Nasdaq-listed company specializing in advanced wound care and healing products, announced it will release its second quarter 2026 operating and financial results on July 29, 2026, followed by a webcast and conference call hosted by senior management.
Clearmind Medicine Inc., a clinical-stage biotech company focused on non-hallucinogenic neuroplastogen-derived therapeutics, announced filing a patent application in Hong Kong for innovative psychedelic compounds aimed at treating PTSD and other mental health disorders. This strengthens the company's global IP portfolio under its exclusive licensin…
3 E Network Technology Group Limited announced the completion of the architectural design and deployment planning for a custom Edge AI System-on-Chip (SoC) tailored for next-generation smart healthcare and eldercare robots developed in partnership with Aladdin Alaris AI. The custom chip addresses critical real-time responsiveness, privacy complianc…
Nexera Technologies Ltd, via its subsidiary KeepZone AI, has facilitated the first purchase order for RT LTA Systems' SkyStar 180 aerostats from a leading homeland security solutions integrator in Mexico. This milestone validates KeepZone's business development efforts and has resulted in the extension of KeepZone's exclusive representation agreeme…
Standard BioTools announced the filing of a registration statement for its all-stock merger with Treeline Biosciences. The combined company, expected to operate as Treeline Biosciences Holdings, Inc. under the ticker TRLN, will have over $900 million in cash at closing to fund operations through 2029. Treeline brings a deep clinical-stage pipeline …
Entergy is converting large data-center commitments into predictable load and contracted economics that should drive visible EPS growth over the next 12-18 months. Valuation at ~30x 2026 EPS already prices growth, but long-term contracts, dividend support, and a constructive regulatory framework justify a selective long trade with defined risk cont…
Frontier Nuclear and Minerals Inc. announced the appointment of Joshua Girnun and Donal Carroll to its Board of Directors ahead of its August 2026 annual meeting. These appointments aim to bring enhanced expertise in metals and mining investment, corporate finance, and public company governance to support Frontier's growth in the nuclear fuel cycle…
Dyne Therapeutics announced FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. The FDA granted Priority Review with a target decision date of January 21, 2027. Z-rostudirsen demonstrated significant dystrophin production increases an…
BrainsWay Ltd., a leader in noninvasive brain stimulation technologies, announced a $3 million minority equity investment in Radial Health, Inc., a company supporting a network of Brain Medicine clinics. This investment supports Radial's Series A financing and its plan to expand clinical infrastructure, reimbursement tools, and AI-based decision su…
Grupo Financiero Galicia (GGAL) trades near book value with a 3.8% yield and heavy exposure to an Argentine credit recovery. With market cap of $8.53B, improving credit demand under recent reform tailwinds and a relatively light float, GGAL offers an asymmetric risk/reward for active traders. We upgrade to Buy and lay out an actionable entry, stop …
IREN Limited announced a significant increase in its 2026 AI Cloud annualized run-rate revenue target from $3.7 billion to over $4 billion, backed by $2.8 billion in new multi-year cloud services contracts with leading AI developers including Microsoft and NVIDIA. The company's AI Cloud capacity is scaling rapidly, supported by strong customer dema…
CoreWeave is a pure-play GPU cloud provider positioned to capture outsized demand from generative AI workloads. We view recent weakness as a tactical buying opportunity: the company benefits from structural capacity tightness, enterprise GPU migration, and favorable contract structures. Our trade plan offers an entry at $50.00, a $80.00 target and …
OKYO Pharma has filed its Annual Report for fiscal year ending March 31, 2026, announcing a robust cash position following a $25 million capital raise. The funds will support the commencement and completion of the FDA-agreed global Phase 3 NEPTUNE trial for its lead drug candidate urcosimod, aimed at treating neuropathic corneal pain. Positive FDA …
Can-Fite BioPharma announced that positive Phase 2a clinical trial results of Namodenoson in advanced pancreatic ductal adenocarcinoma (PDAC) have been accepted for presentation at the prestigious ESMO Congress 2026. The study demonstrated durable disease stabilization and encouraging survival outcomes in a difficult-to-treat patient population, me…
USA Rare Earth announces planned retirement of CEO Barbara Humpton effective October 1, 2026, with Thras Moraitis set to succeed her following the anticipated completion of the merger with Serra Verde by end of August 2026. Michael Blitzer appointed Executive Chairman immediately. The leadership change marks a shift from strategic buildup to operat…
Harrow, a Nasdaq-listed ophthalmic disease management company, announced the presentation of three studies at the ASRS 2026 Annual Meeting that support its ocular anesthetic IHEEZO and biosimilar BYOOVIZ. Early data suggest IHEEZO improves patient experience with less pain and no increased risk of infection. Ongoing QUELL trial enrollment aims to p…
INmune Bio Inc. has successfully completed the transfer of its mesenchymal stromal cell manufacturing process to a commercial-ready stage, meeting MHRA, EMA, and FDA standards. This milestone supports the planned Phase 3 confirmation trial of its product Ebstrocel™, derived from the CORDStrom™ platform for treating recessive dystrophic epidermolysi…
Nephros, Inc., a water technology company specializing in filtration solutions, announced that its CEO Robert Banks will present at the 'Health, Wellness & Longevity' virtual conference hosted by Maxim Group. The conference focuses on innovations in consumer health sectors including beverages, food, supplements, and longevity.
Seer, Inc. is urging its shareholders to vote in favor of its board nominees ahead of the 2026 Annual Meeting, emphasizing the strong qualifications and independence of its directors. The company is countering a proxy challenge from activists seeking to replace several directors with candidates lacking proteomics and life sciences experience, which…
NN, Inc. has successfully entered the US Tier 1 contract manufacturing market for firearm components, securing a multi-million dollar contract with a leading firearms provider. This new venture, part of NN's Defense & Electronics growth strategy, is expected to generate $12-15 million in sales starting Q3 2026 and ramp through 2028. The company's e…
Kratos Defense & Security Solutions announces it will manufacture Elroy Air's Chaparral autonomous cargo aircraft in its expanded Sacramento, California facility, increasing its high-tech workforce and supporting strong commercial and defense demand. The Chaparral is a hybrid-electric, VTOL autonomous cargo aircraft targeting both commercial logist…
Iridex Corporation announced the addition of its EndoProbe® Handpieces to the EyeProGPO product offering, making these disposable laser delivery devices available at preferred pricing to more than 4,300 EyeProGPO members. This expansion strengthens Iridex's collaboration with EyeProGPO and enhances ophthalmology practices' access to innovative reti…
